✦ LIBER ✦

PMH21 COST-UTILITY ANALYSIS OF ANTIDEPRESSANTS FOR SECOND-LINE TREATMENT OF MAJOR DEPRESSIVE DISORDER

✍ Scribed by DC Malone

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH21 BUDGET IMPACT ANALYSIS OF DULOXETI

✍ B Gwiosda; J Rutkowski; P Rys; R Plisko; M Wladysiuk; M Cel; P Mierzejewski; W B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PMH41 COST-UTILITY ANALYSIS OF ESCITALOP

✍ Leshno, M; Ben-Amnon, Y; Brignone, M; Marteau, F; Hansen, K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PMH25 COST-EFFECTIVENESS OF ESCITALOPRAM

✍ N Despiégel; N Danchenko; K Maman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PMH41 COST UTILITY OF EEG BIOMARKERS FOR

✍ KN Simpson; Z Nahas; AF Leuchter; A Siegel; S Greenwald 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PMH46 COST-EFFECTIVENESS ANALYSIS OF ESC

✍ W Kulp; M Hemels; W Greiner; J Schulenburg Graf von der 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PMH26 COST-EFFECTIVENESS ANALYSIS OF ESC

✍ ME Hemels; O Karamustafaloglu; E Ozmen; S Dilsad; S Mene 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB